CD274 and glioblastoma: However, PD-L1 blockade has little therapeutic effect on the growth of recurrent glioblastoma, owing to the TIME, which features chemokines, chemokine receptors, immunosuppressive cytokines, suppressive immune cells, and extracellular vesicles [14].